Ketamine Therapy in Florida

Florida ketamine clinics operate under a framework of federal and state regulations that govern how ketamine may be legally administered. At the federal level, ketamine remains a Schedule III controlled substance under the Controlled Substances Act, meaning it has accepted medical uses but also potential for abuse. Clinics and prescribing physicians must maintain valid DEA registration to purchase, store, and administer the drug. Florida state law aligns with federal scheduling, and all practitioners must hold an active Florida medical license in good standing with the Florida Board of Medicine or the Florida Board of Osteopathic Medicine, depending on their credentials.

In Florida, ketamine infusions for mental health conditions such as depression, PTSD, and anxiety are considered off-label uses, as the FDA has only approved ketamine (in its racemic IV form) as an anesthetic. Esketamine nasal spray (Spravato), however, carries FDA approval specifically for treatment-resistant depression and must be administered under a certified Risk Evaluation and Mitigation Strategy (REMS) program, which requires patients to be observed for at least two hours in a certified healthcare setting after each dose. Clinics offering Spravato must meet these additional federal certification requirements.

Florida does not have a single comprehensive statute dedicated exclusively to ketamine therapy, so clinics are subject to a combination of overlapping regulatory requirements, including:

• Florida Department of Health facility licensing requirements for outpatient surgical centers or office-based surgery settings, where applicable
• DEA controlled substance registration and secure storage protocols
• Informed consent documentation as required under Florida medical practice standards
• Compliance with the Florida Drug and Cosmetic Act for handling and record-keeping of controlled substances
• Adherence to telemedicine prescribing rules if any portion of the intake process occurs remotely

Patients seeking ketamine therapy in Florida are encouraged to verify that their chosen clinic employs a board-certified physician to oversee all infusion protocols and that the facility maintains proper DEA and state licensure. The evolving regulatory landscape, particularly around telehealth-initiated ketamine prescribing, means that standards may shift as state and federal agencies continue to refine oversight of psychedelic-assisted and ketamine-based treatments. Prospective patients can verify a provider's license status through the Florida Department of Health's MQA Online Services portal.